Rob Zenilman submits: Year over year quarterly earnings growth of stocks covered in the Biotech sector ranged from 411.0% (IMCL) down to -95.3% (AFFX), with a median value of 15.9%.
* View More Biotech Sector Charts *
Data in table version -- click on a ticker for
opinion and analysis of the company:
|
|
|
Quarter
|
Earnings
|
Last Yr.
|
YOY
|
| Ticker
|
Company
|
Ending
|
$(mm)
|
($mm)
|
Increase%
|
| AFFX | Affymetrix Inc. | 03/31/06 | $20.04 | $0.93 |
-95.3%
| | ALXN | Alexion Pharmaceuticals I | 03/31/06 | -$23.63 | -$27.32 |
N/A
| | AMGN | Amgen Inc. | 03/31/06 | $1,146.00 | $1,328.00 |
15.9%
| | AMLN | Amylin Pharmaceuticals In | 03/31/06 | -$43.60 | -$67.90 |
N/A
| | BIIB | Biogen Idec Inc. | 03/31/06 | $133.68 | $207.05 |
54.9%
| | BMRN | BioMarin Pharmaceutical I | 03/31/06 | -$22.46 | -$9.28 |
N/A
| | BSTE | Biosite Incorporated | 03/31/06 | $22.34 | $19.81 |
-11.3%
| | CELG | Celgene Corporation | 03/31/06 | $20.92 | $34.31 |
64.0%
| | DNA | Genentech Inc. | 06/30/06 | $461.36 | $806.00 |
74.7%
| | ELN | Elan Corp. plc | 03/31/06 | -$140.80 | -$78.50 |
N/A
| | GILD | Gilead Sciences Inc. | 03/31/06 | $230.79 | $411.17 |
78.2%
| | GPRO | Gen-Probe Inc. | 03/31/06 | $21.11 | $23.06 |
9.2%
| | IMCL | Imclone Systems Inc. | 03/31/06 | $29.22 | $149.29 |
411.0%
| | INCY | Incyte Corp. | 03/31/06 | -$19.94 | -$22.56 |
N/A
| | ISTA | ISTA Pharmaceuticals Inc. | 03/31/06 | -$8.21 | -$10.62 |
N/A
| | KOSP | KOS Pharmaceuticals Inc. | 03/31/06 | $40.36 | -$4.45 |
N/A
| | MEDI | MedImmune Inc. | 03/31/06 | $179.90 | $94.30 |
-47.6%
| | NABI | Nabi Biopharmaceuticals | 04/01/06 | -$22.52 | -$18.08 |
N/A
| | NBIX | Neurocrine Biosciences In | 06/30/06 | -$5.60 | -$27.45 |
N/A
| | ONXX | Onyx Pharmaceuticals Inc. | 03/31/06 | -$16.10 | -$20.35 |
N/A
| | PGNX | Progenics Pharmaceuticals | 03/31/06 | -$13.19 | -$2.64 |
N/A
| | PHRM | Pharmion Corp. | 03/31/06 | $7.19 | $2.96 |
-58.8%
| | TELK | Telik Inc. | 03/31/06 | -$20.42 | -$20.08 |
N/A
| | VRTX | Vertex Pharmaceuticals In | 03/31/06 | -$42.81 | -$50.37 |
N/A
|
Data: CapitalIQ
Note: Net income is before taxes and excludes "unusual" items.
Related:
- Most recent opinion and analysis of Biotech stocks
-
Full transcripts of recent conference calls in the Biotech sector
-
Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a one-page recap of Jim Cramer's Mad Money TV show, Lightning Round, Radio program and Stop Trading?